九州ku酷游

Investor Relations

Announcements

Year

2023

2023

Search

View / Download

2023 / 07 / 10

VOLUNTARY ANNOUNCEMENT - Enrollment in the Phase III Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
View / Download

2023 / 07 / 04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023
View / Download

2023 / 06 / 05

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2023
View / Download

2023 / 05 / 25

POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 MAY 2023
View / Download

2023 / 05 / 05

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2023
View / Download

2023 / 04 / 18

Proxy Form for use at the Annual General Meeting to be held on Thursday, 25 May 2023 or any adjournment thereof
View / Download

2023 / 04 / 18

NOTICE OF ANNUAL GENERAL MEETING
View / Download

2023 / 04 / 18

(1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF DIRECTORS AND CONTINUOUS APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND (3) NOTICE OF ANNUAL GENERAL MEETING
View / Download

2023 / 04 / 12

VOLUNTARY ANNOUNCEMENT - Publication of the Three-Year Follow-Up Results of FIM Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
View / Download

2023 / 04 / 04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2023

14F, LifeTech Scientific Building, Keji 12th Road South, High-tech Industrial Park, Nanshan District, Shenzhen City, Guangdong Province, 518063, PRC

Tel：+86 755 86026250
Fax：+86 755 86026251

Last Updated

Legal Statement Privacy Policy

© 2008-2025 LifeTech Scientific Corporation All rights reserved.

<tr id='GB80A'><strong id='qpjNW'></strong><small id='cR5ET'></small><button id='eKpS2'></button><li id='IU8fa'><noscript id='Ktyji'><big id='97aAt'></big><dt id='3hoU1'></dt></noscript></li></tr><ol id='PDUmo'><option id='5CuJT'><table id='v4Dzw'><blockquote id='WD301'><tbody id='720FY'></tbody></blockquote></table></option></ol><u id='gRDl1'></u><kbd id='8wE3m'><kbd id='e0V2f'></kbd></kbd>

<code id='QFHUB'><strong id='HmnOr'></strong></code>

<fieldset id='QbTF5'></fieldset>

<span id='92ZSu'></span>

<ins id='UX6o7'></ins>

<acronym id='iN80b'><em id='Yri4R'></em><td id='u9CXQ'><div id='3CR7G'></div></td></acronym><address id='ArwWo'><big id='23Tsx'><big id='QLaZg'></big><legend id='3dE3E'></legend></big></address>

<i id='vkaxp'><div id='eDQfM'><ins id='eL0ey'></ins></div></i>

<i id='PEGmG'></i>